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CONFIDENTIALITY OF ALCOHOL AND
OTHER DRUG ABUSE TREATMENT
INFORMATION FOR EMERGENCY
DEPARTMENT AND TRAUMA CENTER
PATIENTS
Richard C. Boldtt
Most persons who receive services related to the diagnosis and
treatment of substance use disorders are protected by confidentiality
rules that far exceed the privacy protections provided to virtually all
other recipients of health-care services. A set of federal laws' and
implementing regulationS2 restrict the disclosure of information about
the treatment of alcohol and other drug (AOD) use disorders. These
laws and regulations contain safeguards that are significantly more
protective of patient confidentiality than ordinary state health privacy
provisions, and are even more robust, in most respects, than those
provided by the federal Health Insurance Portability and Accountabili-
ty Act of 1966 (HIPAA).
t Professor of Law, University of Maryland School of Law. I thank Eileen
Canfield, Diane Hoffmann, and Ellen Weber for their helpfuil comments on an earlier
draft of this article. This work was supported by a research grant from the University
of Maryland School of Law.
' See 42 U.S.C. § 290dd-2 (Supp. IV 1992). The provision relating to the
confidentiality of drug abuse treatment information was initially passed as § 408 of
the Drug Abuse Office and Treatment Act of 1972, Pub. L. No. 92-255, 86 Stat. 65,
79 (codified as amended at 21 U.S.C. § 1175 (1982)). That section was transferred
and amended by Pub. L. 98 -24 to § 527 of the Public Health Service Act, codified at
42 U.S.C. § 290ee-3 (1988 & Supp. V 1993). A similar process led to the codifica-
tion of an identical provision relating to the confidentiality of alcohol abuse treatment
information at 42 U.S.C. § 290 dd-3 (1988 & Supp. V 1993). Both statutes were
amended in 1986 to allow treatment providers to comply with state law child abuse
and neglect reporting requirements. Children's Justice and Assistance Act of 1986,
Pub. L. No. 99 - 401, § 106, 100 Stat. 906 (1986) (amending sections 523(e) and
527(e) of the Public Health Service Act, 42 U.S.C. §§ 290dd-3(e), 290ee-3(e)). In
1992, Congress consolidated the two confidentiality statutes into a single provision
governing both alcohol and drug abuse treatment records.
2 See Confidentiality of Alcohol and Drug Abuse Patient Records, 42 C.F.R.
§§ 2.1-2.67 (2008).
3 The federal AOD confidentiality law and regulations do not permit the
disclosure of confidential information to insurance companies unless the patient has
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In part, the unique legal standing accorded AOD treatment infor-
mation is a response to the considerable stigma long associated with,
and still attached to, substance use disorders. The disclosure of in-
formation identifying an individual as suffering from alcoholism or
other drug use disorders can lead to the loss of employment, occupa-
tional licensing, or public housing.4  Such a disclosure can also
produce legal jeopardy for the individual in the criminal justice and
family law systems.'
executed a detailed written consent form, while HIPAA permits these disclosures
without written patient consent. HIPAA also permits disclosure without written pa-
tient consent to other health-care providers, while the federal AOD law and regula-
tions require either written consent or otherwise limit disclosures to staff within the
program who have a demonstrated need for the information in connection with the
provision of AOD treatment to the patient. HIPAA also is much less rigorous with
respect to the disclosure of patient-identifying information to law enforcement per-
sonnel. Security and Privacy, 45 C.F.R. §§ 164.506(a), 164.504(f)(1), 164.512(f)
(2008); see also Health Insurance Portability and Accountability Act of 1996, Pub. L.
No. 104-191, 110 Stat. 1936, (1996). Pursuant to these regulations, the Department
of Health and Human Services issued regulations, entitled the Privacy Rule, to im-
plement the Act; see C.F.R. Part 160, 164 (2002). The Office for Civil Rights within
HHS has responsibility for enforcing these provisions. See Larry M. Gentilello et al.,
Alcohol Screening and Intervention in Trauma Centers: Confidentiality Concerns and
Legal Considerations, 59 J. TRAUMA 1250, 1250-51 (2005).
4 See, e.g., Mararri v. WCI Steel, Inc., 130 F.3d 1180 (6th Cir. 1997);
Teahan v. Metro-North Commuter R. Co., 951 F.2d 511 (2d Cir. 1991); see also
Burch v. Coca-Cola, Co., 119 F.3d 305 (5th Cir. 1997) (claim under Title I of the
ADA by manager who was terminated from employment after entering in-patient
alcoholism treatment); 21 U.S.C. § 862a (2000) (providing for the exclusion of per-
sons involved in drug-related activities from federally assisted public housing). A
poll conducted in 2001 for Faces and Voices of Recovery by Peter D. Hart Research
Associates found that twenty-four percent of people in recovery report having suf-
fered employment and/or insurance discrimination, with twelve percent reporting they
had personally been denied a job or promotion. See PETER D. HART RESEARCH
Assocs., INC., THE FACE OF RECOVERY (2001), http://facesandvoicesofrecovery.org/
pdf/hart research.pdf.
See, e.g., Ellen M. Weber, Child Welfare Interventions for Drug-
Dependent Pregnant Women: Limitations of a Non-Public Health Response, 75
UMKC L. REV. 789 (2007) (arguing that the child welfare system lacks capacity to
help drug-dependent pregnant woman change their behavior). Professor Weber de-
scribes research suggesting that some "drug-using pregnant women avoid the health
care system because they fear that the detection of their drug use will result in puni-
tive actions, including the possible removal of a child from her custody." Id. at 793,
n. 1 (citing Barry M. Lester et al., Substance Use During Pregnancy: Time for Policy
to Catch Up with Research, 1 HARM REDUCTION J. 5 (2004), available at
http://www.harmreductionjoumal.com/content/1/l/5. Although the Americans with
Disabilities Act provides some statutory protection against discrimination based on
current alcoholism or past drug use disorders, it does not protect against discrimina-
tion based upon ongoing illegal drug abuse. See Americans with Disabilities Act, 42
U.S.C. §§ 12101-12213, 12114 (2006).
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In addition, the stringent AOD confidentiality rules are very much
a product of the fact that alcohol and other drug abuse treatment
services historically have been delivered in the United States in spe-
cialized (segregated) institutional settings by specialized treatment
providers.6 The unusually restrictive rules governing the disclosure of
this information were designed to insure that persons in need of treat-
ment for substance use disorders regard that specialized treatment
system as safe to access.
There is a movement underway, however, to begin "mainstream-
ing" the diagnosis and treatment of substance use disorders. 8  This
effort has been propelled by a conviction that integrating AOD treat-
ment services into the broader health-care delivery system would like-
ly reduce the stigma associated with alcoholism and other drug use
disorders, by approaching those disorders as treatable conditions ra-
ther than instances of willful misconduct. In addition, proponents of
mainstreaming emphasize that an integrated health-care delivery
model would more effectively address the myriad ways that AOD
abuse either causes other diseases or co-occurs with them. 9 Finally,
proponents point out that the misuse of alcohol and other drugs occurs
across a continuum, and that only those persons whose abuse falls at
6 See Daniel W. Hungerford, Interventions in Trauma Centers for Substance
Use Disorders: New Insights on an Old Malady, 59 J. TRAUMA SI 0, S14 (2005).
7 The federal AOD treatment confidentiality legislation and the original
implementing regulations promulgated in the 1970s by the Department of Health,
Education and Welfare set out policy objectives that reflect both a concern about the
negative consequences that untoward disclosure of treatment information can have for
individuals with substance use disorders, given the stigma associated with these con-
ditions, and a concern that such disclosures can do damage to the broader delivery
system for AOD treatment services. See 42 C.F.R. §§ 2.1-2.67. In effect, the as-
sumption has been that, if all treatment providers adhered to a comprehensive and
rigorous confidentiality scheme, individuals with substance use disorders would be
more likely to seek treatment for these highly stigmatized conditions. The protections
provided by the federal laws and regulations are not held simply by the patient; in-
stead, because of the overarching goal of promoting a general perception that this
specialized system rigorously maintains patient confidentiality, the regulations gener-
ally regard the treatment program and the "treatment system" as entities presenting
interests of equal importance to those of the individual patient. § 2.33. Thus, for
example, in Subpart E of the regulations, which governs court orders for the disclo-
sure of drug or alcohol abuse treatment information, judges are directed to give
weight to the interests of the "treatment system" in maintaining patient confidentiality
as an element of determining whether good cause exists. §§ 2.61-2.67.
8 See Gentilello et al., supra note 3, at 1250, 1253-54.
9 For example, roughly half of all cases of cirrhosis, pancreatitis, and can-
cers of the esophagus, larynx and mouth are attributable to alcohol abuse. See
Richard Saitz, Unhealthy Alcohol Use, 352 NEw ENG. J. MED. 596, 597 (2005). In
addition, alcohol abuse or dependence often co-occurs with hypertension, depression,
anemia, and anxiety disorders. Id.
the more severe end of the continuum require the sort of intensive
addiction treatment services that are traditionally offered in specia-
lized, segregated programs.10
Notwithstanding the urging of some public health and other
health-care experts to begin a process of integrating AOD services by
encouraging the adoption of a standard under which all patients pre-
senting for medical care would be screened for alcohol and other drug
use disorders," the diagnosis and treatment of these conditions has for
the most part continued to remain confined to specialized addictions
treatment services within the heath-care delivery system.12 One im-
portant exception to this pattern that has begun to emerge, however,
involves the provision of AOD screening and other AOD treatment
and referral services by medical personnel in emergency departments
and trauma centers. In 2006, the Committee on Trauma (COT) of the
American College of Surgeons revised its Optimal Resources Manual.
The revision requires that all Level I and II trauma centers in the
United States screen patients for alcohol problems and requires all
Level I trauma centers to implement a protocol for providing brief
counseling interventions to patients who screen positive for alcohol
abuse. In effect, these provisions in the COT's new manual require
facilities to have the capacity to conduct alcohol screening and inter-
ventions in order to maintain certification as a Level I trauma center.' 3
Given the close correlation between substance use disorders and
traumatic injury, it is not surprising that some emergency departments
and, especially, trauma centers have taken the lead in integrating AOD
diagnosis and treatment services into their broader agendas. Alcohol
intoxication is the leading risk factor for injury, and alcohol misuse is
present in approximately half of all trauma cases and one-quarter of
Io See Hungerford, supra note 6, at S 1l; see also AM. COLL. OF SURGEONS ET
AL., ALCOHOL SCREENING AND BRIEF INTERVENTION (SBI) FOR TRAUMA PATIENTS:
COT QUICK GUIDE 3, http://www.facs.org/trauma/publications/sbirtguide.pdf (last
visited May 3, 2010) (reporting that "[flor every U.S. adult who is dependent on
alcohol, more than 6 other adults who are not dependent are at risk of or have already
experienced problems from their drinking.").
" See, e.g., COMM. ON TREATMENT OF ALCOHOL PROBLEMS, INST. OF MED.,
BROADENING THE BASE OF TREATMENT FOR ALCOHOL PROBLEMS (1990).
12 See NAT'L CTR. ON ADDICTION & SUBSTANCE ABUSE, MISSED
OPPORTUNITY: NATIONAL SURVEY OF PRIMARY CARE PHYSICIANS AND PATIENTS IN
SUBSTANCE ABUSE 5 (2000), http://www.casacolumbia.org/articlefiles/380-Missed
%200pportunity/o20Physicians%20and%20Patients.pdf (reporting that "[p]hysicians
are not screening their patients carefully for substance abuse. Nearly ninety-four
percent of them fail to accurately diagnose an alcohol problem in adults. Forty percent
miss an illegal drug abuse diagnosis in teens.").
13 See AM. COLL. OF SURGEONS, RESOURCES FOR OPTIMAL CARE OF THE
INJURED PATIENT (2006).
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all emergency department admissions. 14 In addition, at least twenty-
five percent of patients whose injuries are associated with alcohol
misuse return to the hospital for emergency care within one year of
their initial visit as a consequence of new injuries." For some patients
who are "problem drinkers" but who are not alcohol dependent,1 6 this
pattern of recidivism can be interrupted by brief counseling
interventions that leverage the obvious and apparent connection be-
tween substance misuse and injurious consequence to support positive
behavioral change.17 Those patients who are screened as alcohol de-
pendent upon their admission to an emergency department or trauma
center by unit staff can be referred for detoxification and more inten-
sive aftercare services.'
The available data suggest that the practice of providing screening
and either brief interventions or referrals for more intensive AOD
14 See Larry M. Gentilello et al., Alcohol Interventions for Trauma Patients
Treated in Emergency Departments and Hospitals, 241 ANNALS SURGERY 541, 541
(2005); Carol A. Soderstrom et al., Alcoholism at the Time of Injury Among Trauma
Center Patients: Vehicular Crash Victims Compared with Other Patients, 29
ACCIDENT ANALYSIS & PREVENTION 715, 715, 719-20 (1997); see also Carol A.
Soderstrom et al., Psychoactive Substance Dependence Among Trauma Center Pa-
tients, 267 JAMA 2756, 2756 (1992) (citing trauma center statistics regarding the role
of alcohol in serious injuries). Much of the discussion and most of the available
studies in this area concentrate on alcohol misuse and dependence. This makes sense,
given that alcohol is the most frequently used drug of abuse. Indeed, more than
75,000 deaths each year in the United States are the result of alcohol problems. Ctrs.
for Disease Control & Prevention, Injury Prevention & Control: Injury Response,
Alcohol Screening, http://www.cdc.gov/InjuryResponse/alcohol-screening/ [hereinaf-
ter Alcohol Screening]. Nevertheless, the analysis applies with equal force to other
substance use disorders. In a considerable number of cases, alcohol abuse or depen-
dency occurs in combination with other drug misuse or dependency. In a study of
drug-related emergency department visits in 2004, for example, the Department of
Health and Human Services' Substance Abuse and Mental Health Services Adminis-
tration (SAMHSA) reported that alcohol in combination with illegal drug use was
involved in 338,638 emergency department visits out of a total of 1.6 million visits
associated with drug misuse or abuse. OFFICE OF APPLIED STUDIES, U.S. DEP'T OF
HEALTH & HUMAN SERVS., DRUG ABUSE WARNING NETWORK, 2004: SELECTED
TABLES OF NATIONAL ESTIMATES OF DRUG-RELATED EMERGENCY DEPARTMENT VISITS
(2009), https://dawninfo.samhsa.gov/files/ED2004/2004EDTables.pdf.
15 See Rosemary Frei, ACS Trauma Committee Takes Decisive Step Against
Alcohol Abuse, GEN. SURGERY NEWS (2006) (on file with author).
16 On the distinction between alcohol and other drug dependency versus
problem drinking and other risky drug use behaviors, see Saitz, supra note 9, at 597-
98. See also infra text accompanying notes 112-117.
7 See Chris Dunn et al., The Stages of Change: When are Trauma Patients
Truly Ready to Change?, 59 J. TRAUMA S27 (2005) (suggesting the Stages of Change
(SOC) model enhances such interventions).
18 See Hungerford, supra note 6, at S14.
treatment can produce dramatic results. 9 The authors of several care-
fully designed studies have reported "substantial decreases in reinjury
rates" following the provision of brief interventions in the acute injury
context. 20  Other researchers have reported reduced rates of subse-
quent hospitalizations, and at least one study has documented signifi-
cant cost savings associated with the implementation of screening and
intervention practices.2 1
Despite these encouraging statistics and broad support among
trauma surgeons and other emergency medical personnel,22 many
trauma centers and emergency departments still do not provide syste-
matic screening and intervention services for all patients. 23 One inhi-
bitor is the persistence of state laws modeled on the Uniform Accident
and Sickness Policy Provision Law, which is a model statute devel-
oped in the 1940s that allows insurance carriers to exclude coverage
for treatment of injuries that are related to alcohol or other drugs. 2 4
Another inhibitor is a perception on the part of some treatment pro-
viders that AOD treatment is ineffective or that treatment resources
are scarce or unavailable. 25
Several experts have suggested, however, that the special confi-
dentiality rules governing AOD treatment information also may have
an inhibiting effect on the willingness and ability of providers to en-
gage in systematic screening, intervention, and referral activities.
These experts caution that emergency department and trauma center
staff may be unwilling to undertake activities covered by the AOD
confidentiality regulations because they do not want to be constrained
in their ability to share information freely with other clinicians in-
volved in the care of their patients, and do not wish to incur the consi-
derable administrative costs associated with maintaining segregated
19 Gail D'Onofrio & Linda C. Degutis, Preventive Care in the Emergency
Department: Screening and Brief Intervention for Alcohol Problems in the Emergen-
cy Department: A Systematic Review, 9 ACAD. EMERGENCY MED. 627, 630-31 (2002).
20 Gentilello et al., supra note 14, at 544.
21 See id. at 544, 546-47.
22 See Larry M. Gentilello et al., Effect of the Unform Accident and Sickness
Policy Provision Law on Alcohol Screening and Intervention in Trauma Centers, 59
J. TRAUMA 624,629-30 (2005).
23 See Carol R. Schermer et al., National Survey of Trauma Surgeons' Use of
Alcohol Screening and Brief Intervention, 55 J. TRAUMA 849 (2003) (finding, among
other things, that twenty-five percent of trauma surgeons use formal alcohol screening
questionnaires).
24 See Gentilello et al., supra note 22, at 624, 629-30.
25 See CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., TIP 16: ALCOHOL AND OTHER DRUG SCREENING OF HOSPITALIZED
TRAUMA PATIENTS ch. 1 (1995), http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book
=hssamhsatip&part-A3648 1.
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patient files, as the AOD regulations may require. More broadly,
these writers suggest that complying with the special confidentiality
rules would diminish the ability of clinicians and administrators to
centralize information systems and integrate treatment services. Con-
sequently, they suggest that amendments to the federal confidentiality
statute and its implementing regulations may be in order, if this first
step toward mainstreaming substance use disorder treatment is to take
hold.
This article explores the confidentiality issues raised by the grow-
ing movement to provide AOD screening and interventions in emer-
gency departments and trauma centers. First, it examines the clinical
context within which hospitalized trauma patients receive, or poten-
tially might receive, these services. Then, it analyzes the federal AOD
confidentiality law and regulations to determine whether, and under
what circumstances, these provisions might apply to the kinds of
screening and intervention activities the COT requires. The funda-
mental problem identified in this analysis is that the rules inadequately
address situations in which AOD information is obtained both for
purposes of the medical management of patients' acute injuries or
illnesses and also as part of a general program of screening and inter-
vention. The analysis demonstrates that, even when read in the con-
text of their promulgation history and subsequent judicial interpreta-
tion, it is not clear whether the federal AOD regulations apply to the
kinds of assessment, intervention, and referral activities the COT poli-
cy contemplates. On one level, this legal indeterminacy is the result
of the federal regulations' inadequate consideration of the problem of
multiple functions. On another level, it reflects the failure of the draf-
ters of these provisions to appreciate that AOD problems occur along
a continuum of severity, and that persons who are not substance
dependent but who nevertheless have problems associated with the
misuse of alcohol or other drugs may most effectively be helped by
interventions outside of the specialized addiction treatment network.
Framed in this way, the precise question is whether diagnosis and
counseling functions directed at individuals in the middle of the conti-
nuum and at the less severe end should be regarded as AOD "treat-
ment" within the coverage of the regulations.
Assuming that the federal AOD confidentiality law and regula-
tions do apply to screening and intervention activities in emergency
department and trauma care settings, the article concludes with some
observations about the broader question of whether the law and regu-
lations should be revised, given the obvious benefits of mainstreaming
26 See, e.g., Gentilello et al., supra note 3, at 1253-54.
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substance abuse treatment on the one hand, and the continuing stigma
and legal jeopardy associated with the disclosure of AOD disorders on
the other. Although creating a limited use exception for AOD screen-
ing and intervention activities when undertaken by emergency de-
partments and trauma centers may be worth considering, this article
argues that there is considerable flexibility already in the law to ac-
commodate the interests in tension here. On balance, the best course
likely will be to maintain the confidentiality regime currently in place
for alcohol and other drug abuse treatment information, at least for the
foreseeable future.
I. THE PROVISION OF ALCOHOL AND OTHER DRUG
USE DISORDER SCREENING, ASSESSMENT AND
INTERVENTION SERVICES TO HOSPITALIZED
TRAUMA PATIENTS
Approximately 110 million patients are treated annually in hospit-
al emergency departments in the United States, and at least 3.5 million
injured persons are admitted for care in U.S. trauma centers each
27
year. Research drawn from a number of samples of hospitalized
trauma patients over a period of almost two decades consistently has
shown that at least forty percent and as much as eighty percent of this
population tests positive for alcohol or other drugs upon their admis-
sion for emergency treatment. 2 8 Given the sheer number of injured
patients who pass through the system and the well established evi-
dence of a substantial co-occurrence of traumatic injury and AOD use,
it is not surprising that emergency departments and trauma centers
increasingly have sought to provide systematic screening, assessment,
and intervention services for their patients.
Traditionally, emergency department and trauma center staff were
oriented clinically toward treating their patients' presenting conditions
rather than providing preventive services. More recently, however,
public health experts and health-care providers within emergency de-
partments and trauma centers have begun to adopt a "new perspec-
tive" in which accidental injury is viewed as a disease, not unlike
heart disease, diabetes, or cancer.2 9 When injuries are viewed in this
way, treating professionals are more likely to understand their role to
27 See Alcohol Screening, supra note 14.
28 See CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 4.
29 See, e.g., R. Martinez, Injury Prevention: A New Perspective, 272 JAMA
1541, 1541-42 (1994) (acknowledging the increasing role of injury prevention in
medical care).
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include the exploration of underlying causes and the presentation of
interventions designed to reduce future harm. Moreover, given the
prevalence of AOD misuse among patients presenting at hospitals
with accidental injuries, and given research demonstrating that pa-
tients who were intoxicated at the time of an initial injury are two and
one-half times more likely than other patients to suffer re-injury with-
in an eighteen-month period, providing AOD screening and interven-
tions makes sense.30 Just as we would expect a heart attack patient to
receive counseling about exercise and diet as a regular component of
his or her treatment, so too should a patient who has suffered traumat-
ic injury, due to alcohol or other drug use, receive focused interven-
tions calculated to prevent re-injury.31
The screening 32 of patients for alcohol and other drug abuse is a
preliminary step that often precedes a more intensive assessment of
those individuals who have had positive screens to determine if they
have substance use disorders for which treatment or other interven-
tions are appropriate. The initial AOD screening serves a number of
useful functions, which include assisting in the medical management
of trauma patients33 and identifying persons at risk of re-injury. In
addition, the screening may lead to therapeutic interventions designed
to reduce AOD misuse and dependency. Such screening can be ac-
complished through laboratory tests, screening interviews and ques-
tionnaires, or a combination of both physical and nonphysical tests.
The most commonly employed laboratory tests measure the presence
of alcohol in the patient's blood ("blood alcohol concentration" or
"BAC") or the presence of other drugs in the patient's urine ("urine
drug screening").34 These tests indicate recent substance use, but do
30 See, e.g., Frederick P. Rivara et al., The Effects of Alcohol Abuse on
Readmission for Trauma, 270 JAMA 1962 (1993).
31 See CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 1.
32 Screening is defined as "the application of a simple test to a group of per-
sons for the purpose of identifying a subgroup with a certain condition." See id at ch.
4. Screening tests are usually described in terms of their "specificity," which is their
capacity to exclude individuals who do not have the target condition, and "sensitivi-
ty," which is their ability "to detect the target condition in a given population when it
is present." Id.
33 Alcohol and other drug screening is important in the medical management
of emergency and trauma patients in a number of respects. See id at ch. 3. Issues
with respect to anesthesia and pain management may be directly implicated by a
patient's substance abuse. Id. In addition, medical staff may be involved in provid-
ing care during withdrawal. Id.
34 Other tests include saliva tests and breathalyzer tests. See id. at ch. 4. In
addition, chronic alcohol use can be determined in some instances through the use of
tests that measure injury to liver cells and to the cells that manufacture red blood
not necessarily indicate either AOD dependence or chronic misuse.35
Consequently, many clinicians believe that laboratory test results
should be interpreted alongside the results of other screening instru-
ments. A wide variety of questionnaires and structured interviews are
available for use by clinicians who wish to employ this combination
of laboratory testing and other nonphysical screening tools.36
Once a positive AOD screen has occurred, the patient may under-
go a comprehensive assessment to determine if he or she has a sub-
stance use disorder, including chronic misuse and/or dependency, and
would benefit from either a brief intervention or a referral for more
intensive treatment. While most or all of the commonly used screen-
ing techniques can be employed by emergency department or trauma
center personnel without specialized training in substance use disord-
ers, assessments should be performed by a specialized clinician."
The assessment process generally includes an initial encounter with
the patient and may also involve follow-up sessions, if the patient
remains hospitalized and other features of the assessment process war-
rant additional meetings. The assessor may employ well developed
assessment instruments, such as the widely adopted Assessment
Severity Index ("ASI"),38 but whether or not such a tool is used, the
cells. Id.
3 See id. On the other hand, positive urine drug screens do not necessarily
provide clear evidence of impairment at the time of injury, because the metabolites of
some drugs remain detectable in a patient for days or weeks after use. Id.
36 A number of questionnaires are available to assist in identifying persons
with alcohol or other drug use disorders. One of the most widely employed instru-
ments is the Alcohol Use Disorders Identification Test (AUDIT), which is a ten item
questionnaire developed in conjunction with the World Health Organization. AUDIT
contains questions about alcohol use in the preceding year and about alcohol-related
problems. See Thomas F. Babor et al., World Health Org. [WHO], A UDIT: THE
ALCOHOL USE DISORDERS IDENTIFICATION TEST: GUIDELINES FOR USE IN PRIMARY CARE
(2nd ed., 2001), http://whqlibdoc.who.int/hq/2001/WHO MSD MSB 01.6a.pdf.
Other frequently used screening instruments include CAGE, which contains four
questions designed to identify persons who are alcohol dependent, and BMAST (Brief
Michigan Alcoholism Screening Test), which contains ten questions. See CTR. FOR
SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH & HUMAN SERVS., supra note
25, at ch. 4.
3 These specialists include physicians, nurses, social workers, addictions
counselors and physicians' assistants. See CTR. FOR SUBSTANCE ABUSE TREATMENT,
U.S. DEP'T OF HEALTH & HUMAN SERVS., supra note 25, at ch. 4.
38 See generally A.Thomas McLellan et al., An Improved Diagnostic Evalua-
tion Instrument for Substance Abuse Patients: The Addiction Severity Index, 168 J.
NERVOUS & MENTAL DISEASE 26 (1980) (proposing the Addiction Severity Index
(ASI) as "standardized diagnostic and evaluative instrument in the field of alcohol
and drug abuse" and suggesting its use to match patients with various treatment op-
tions).
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assessor's job is to piece together a comprehensive picture of the pa-
tient's AOD use in context. This picture is likely to include informa-
tion drawn from the screening tests, the assessor's initial interview
with the patient, the patient's medical and psychiatric histories, and
his or her social, occupational, family, and legal circumstances.39
Plainly, this process of gathering information raises significant
confidentiality considerations. Virtually every component of the as-
sessor's investigation has the potential to communicate sensitive
AOD-related information about the patient to others, to require the
disclosure of sensitive information to the assessor, or both. Even the
location of the initial interview can be tricky from a confidentiality
standpoint; if, for example, the patient does not have a bed in a private
hospital room. The gathering of medical and psychiatric information
from the patient's written chart or from discussions with other medical
caregivers also has implications with respect to the confidentiality
interests protected by the federal AOD law and regulations. And con-
versations with family members, friends, employers, and others pose a
significant risk that information will be shared that could have serious
consequences for the patient in terms of child custody, employment,
criminal justice issues and the like.40
The comprehensive assessment often goes beyond information ga-
thering, and may also include the development, in appropriate cases,
of a forward-looking plan of intervention. Depending on the asses-
sor's findings, the patient could receive little more than a brief educa-
tional intervention and advice about alcohol and other drug use and
misuse, or he or she could receive an intervention, still brief in length,
more explicitly focused on changing the patient's behavior and/or
preparing the patient to accept the need for more intensive longer-term
AOD treatment.4 1 In some instances, the initial interview with the
assessor may serve as a therapeutic intervention as well. 42
3 See CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 4.
40 See id.
41 See Craig Field et al., Brief Motivational Interventions: An Introduction,
59 J. TRAUMA S21, S24-26 (2005). In foundational research conducted in the early
1960s, Chafetz found that only about one percent of emergency department patients
who were referred to alcohol and other drug abuse treatment after discharge actually
kept their appointment. When a brief intervention conducted by a trained AOD coun-
selor was offered before discharge, however, the show up rate for aftercare increased
to forty-two percent. Morris E. Chafetz, A Procedure for Establishing Therapeutic
Contact with the Alcoholic, 22 Q.J. STUD. ALCOHOL 325, 326-27 (1961).
42 See CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 4.
For patients who have problems with AOD use but who do not
require specialized clinical services related to withdrawal from alco-
hol or other drugs or other intensive AOD treatment, the provision of
a brief counseling intervention may make a significant difference in
reducing AOD misuse and the related likelihood of future traumatic
injury. A number of studies conducted in the 1980s and 1990s dem-
onstrated that even relatively simple counseling sessions could sub-
stantially reduce alcohol consumption among heavy drinkers. In one
British study, a randomly assigned group was provided information
comparing individuals' weekly alcohol intake with national averages,
along with a diary to record their ongoing alcohol use. In addition,
these individuals were given written information about how to mod-
erate their drinking. Twelve months later, this study group exhibited a
twofold reduction in their alcohol consumption relative to the control
group.4 3 In another multinational study sponsored by the World
Health Organization, a range of brief interventions all produced sig-
nificantly reduced levels of alcohol consumption. These results held
up even in the group that received the most minimal intervention and
were consistent in ten different countries with widely differing cultur-
al norms with respect to drinking." More recent studies of brief
interventions provided within emergency departments and trauma
centers have reported similar results. 45
While the specific details of AOD interventions vary from one
program to the next, researchers have begun to identify certain com-
mon features that appear to make these practices successful. Miller
43 Paul Wallace et al., Randomised Controlled Trial of General Practitioner
Intervention in Patients with Excessive Alcohol Consumption, 297 BRIT. MED. J. 663,
664, 666 (1988).
4 In the study sponsored by the World Health Organization, the brief inter-
ventions consisted of either a single five minute session on sensible drinking, a single
fifteen minute counseling session, or a brief initial counseling session and several
follow up sessions. World Health Org. [WHO], Project on Identification and Man-
agement of Alcohol-Related Problems: Report on Phase II: A Randomized Clinical
Trial of Brief Interventions in Primary Health Care, at 18, 241, 243-45,
WHO/PSA/91.5 (Thomas F. Babor & Marcus Grant eds., 1992), http://whqlibdoc
.who.int/hq/1991/WHOPSA_91.5.pdf.
45 See, e.g., Anne Moyer et al., Brief Interventions for Alcohol Problems: A
Meta-Analytic Review of Controlled Investigations in Treatment-Seeking and Non-
Treatment Seeking Populations, 97 ADDICTION 279 (2002) (summarizing "additional
positive evidence for brief interventions compared to control conditions typically
delivered by health-care professionals to non-treatment-seeking" individuals); see
also Kari Poikolainen, Effectiveness of Brief Interventions to Reduce Alcohol Intake
in Primary Health Care Populations: A Meta-Analysis, 28 PREVENTATIVE MED. 503,
503-04 (1999) (studying the effects of brief intervention delivered to the general
population and patients of family or general practitioner practices).
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and Sanchez have set out six elements, captured by the acronym
FRAMES, that typically are found in well-designed programs. These
elements are "feedback, responsibility, advice, menu, empathy, and
self-efficacy." 4 6 More generally, experts in this area suggest that the
key to success is to motivate the patient to adopt safer AOD-related
behaviors by providing objective information about past AOD use, by
making the patient an active participant in setting goals for future be-
havior, and by providing empathic support and encouragement.47 In
addition, interventions may involve working with the patient to identi-
fy barriers to change and to plan concrete steps that he or she can take
to effectuate recovery. Perhaps most important, because the actual
intervention occurs at a "teachable moment," it provides an opportuni-
ty for the patient to begin to link his or her misuse of alcohol or other
drugs with the injury that has occasioned his or her hospitalization
and, by extension, to link a change in that behavior with the possibili-
ty of a reduced risk of future traumatic injury.48
As more emergency departments and trauma centers provide
AOD-related services ranging from initial screening to comprehensive
assessment to intervention, counseling, and referral activities, the
question of patient confidentiality increases in salience. It may be that
systematic screening of all patients, which often is accomplished by
medical staff without any specialization in AOD treatment and often
undertaken for multiple purposes including the medical management
of trauma injuries, is subject to a different (and less demanding) set of
confidentiality rules than are the assessment and counseling activities
more commonly conducted by AOD specialists. Further, the applica-
bility of the federal confidentiality regulations may depend on wheth-
er the AOD specialists who do this work formally are part of the
emergency department or trauma unit staff. These and other related
issues turn on the language of the federal AOD confidentiality law
and regulations and the interpretations of that language that have been
offered by officials at HHS and the courts. We now turn to a consid-
eration of these materials.
46 William R. Miller & Victoria C. Sanchez, Motivating Young Adults for
Treatment and Lifestyle Change, in ALCOHOL USE AND MISUSE BY YOUNG ADULTS 55,
61-63 (George S. Howard & Peter E. Nathan eds., 1993).
47 See generally Field et al., supra note 41 (discussing brief motivational
interventions and contrasting such methods with more traditional approaches to pa-
tient-provider interaction); see also CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S.
DEP'T OF HEALTH & HUMAN SERVS., supra note 25, at ch. 4.
48 See id.; see also AM. COLL. OF SURGEONS ET AL., supra note 10, at 9-10.
II. THE FEDERAL ALCOHOL AND OTHER DRUG
TREATMENT CONFIDENTIALITY LAW AND
REGULATIONS
In the early 1970s, Congress passed two statutes designed to pro-
tect the confidentiality of persons who apply for or receive treatment
for alcohol or other drug use disorders.4 9 The Department of Health,
Education, and Welfare ("HEW"), the agency responsible, at the time,
for implementing these laws, then promulgated regulations detailing
the obligations of treatment programs with respect to these statutes.50
In 1987, HEW's successor, the Department of Health and Human Ser-
vices ("HHS"), issued a revised set of confidentiality regulations,"
and in 1994 the agency proposed several additional amendments.5 2
These regulations, as so amended, currently apply to all federally as-
sisted AOD treatment programs.
In order to accomplish its dual objectives of protecting the health
privacy of individual patients and the overall integrity of the specia-
lized AOD treatment system, 4 the current federal confidentiality law
and regulations articulate a general prohibition against disclosure.
Thus, unless one of a limited number of exceptions applies, the gener-
al rule is that a federally assisted AOD treatment program may not
disclose any information that would identify a person as a patient who
has sought or received substance abuse treatment.5 5
The broad definitions of key terms insure that this fundamental
prohibition on disclosure is both expansive and robust. Thus, the regu-
lations define a "program"f as "an individual or entity . .. who holds
itself [sic] out as providing, and provides, alcohol or drug abuse diag-
49 See 42 U.S.C. § 290dd (1992); see also Richard C. Boldt, Rehabilitative
Punishment and the Drug Treatment Court Movement, 76 WASH. U. L.Q. 1205, 1267-
68 (1998) (describing the confidentiality problems faced by defense attorneys arising
from the close relationship between drug treatment court judges, prosecutors, and
treatment providers); Richard C. Boldt, A Study in Regulatory Method, Local Political
Cultures, and Jurisprudential Voice: The Application of Federal Confidentiality Law
to Project Head Start, 93 MICH. L. REv. 2325, 2330 n.14 (1995) (noting the legal
deficiencies apparent in the application of confidentiality laws and regulations to
substance abuse-related services of Head Start).
50 Confidentiality of Alcohol and Drug Abuse Patient Records, 42 C.F.R. §§
2.1-2.67 (2008).
s' For a discussion of these amendments, see infra text accompanying notes
74-75.
52 For a discussion of these amendments, see infra text accompanying notes
82-88.
S3 42 C.F.R. §§ 2.1-2.67.
S4 See supra text accompanying note 7.
ss 42 C.F.R. §§ 2.12-2.13(a).
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nosis, treatment, or referral for treatment."5 6 Further, the regulations
define a "disclosure" as any oral or written "communication of pa-
tient-identifying information."57 Even the mere conformation of in-
formation that a recipient already possesses is deemed to be a disclo-
sure.58 The term "patient" includes any person who has applied for or
received diagnosis or treatment. 59 "Diagnosis" is defined as "any ref-
erence to an individual's alcohol or drug abuse or to a condition which
is identified as having been caused by that abuse which is made for
the purpose of treatment or referral for treatment." 60 "Treatment," in
turn, "means the management and care of a patient suffering from
alcohol or drug abuse, a condition which is identified as having been
caused by that abuse, or both, in order to reduce or eliminate the ad-
verse effects upon the patient."61 In effect, a person becomes a "pa-
tient" entitled to protection under the federal regulations once he or
she has received an interview, counseling, or any other related diag-
nostic, referral, or treatment service by a covered treatment program,
even if the individual is not ultimately admitted for ongoing care.62
The regulations provide a limited number of exceptions to the
general rule proscribing the disclosure of AOD diagnosis and treat-
ment information. Several of these exceptions stem from the basic
definitions that construct the fundamental prohibition. In order for a
communication of information to be a "disclosure," and therefore sub-
ject to the federal restrictions, it must identify a person as an AOD
"patient." Thus, a communication that is anonymous, that does not
link an individual to an AOD treatment provider (which may be poss-
ible when the program conveys information through an "umbrella"
agency such as a general hospital or county public health department),
56 § 2.11. The 1987 amendments to the regulations changed this definition to
make clear that an entity will not be considered a "program" unless it "holds itself
out" as providing substance abuse-related services. Id. In addition, the amended
regulations added a special provision that limits their application to specialized per-
sonnel within a general hospital or community mental health center. Id. For a more
detailed analysis of the effect of these amendments, and their interpretation by several
courts, see infra text accompanying notes 74 to 100. A program is "federally as-
sisted" within the meaning of the federal laws and regulations if it receives federal
funds in any form (including the receipt of Medicaid or Medicare reimbursement),
has a grant of tax-exempt status from the Internal Revenue Service, is licensed by the
federal government, or is conducted directly by the federal government. 42 C.F.R. §§
2.12(b).
" § 2.11.
s Id.
6 2 Id.
60 id.
61 id.
62 § §2.11, 2.12(e)(4).
or that appears in the form of aggregate data is not prohibited.
Moreover, a communication of information that is patient-identifying
is still not a prohibited disclosure if it takes place "within a program,"
so long as the recipient of the protected information has a need for this
information in connection with his or her duties in the provision of
AOD treatment to the patient."6 Other exceptions exist for patient-
identifying disclosures in cases of "medical emergency,",6 when a
crime has been threatened or committed on program premises or
against program staff,66 when program personnel suspect that a patient
is engaged in child abuse or neglect,67 or when a court has issued a
proper court order. 6 8 Furthermore the federal regulations permit dis-
closure of patient information pursuant to a properly executed written
patient consent form, which can be critical in the everyday operation
of treatment programs.69
In determining whether hospital emergency departments and
trauma centers are subject to the federal confidentiality law and regu-
lations, a key question is whether AOD screening, intervention, and
63 See § 2.11 (defining "patient identifying information").
6 § 2.12(c)(3). The regulations also permit the communication of patient-
identifying information to outside entities that provide services in support of the pro-
gram's AOD diagnosis and treatment functions, if the outside entity enters into a
"qualified service organization" agreement in which it agrees to treat any patient-
identifying information it receives with full confidentiality. Essentially, this sort of an
agreement brings the outside service provider into the program, thus converting the
disclosure into an internal communication. § 2.12(c)(4).
65 § 2.51. This exception is limited to extremely serious circumstances, and
only "medical personnel" may receive patient-identifying information. See id.
66 § 2.12(c)(5).
67 § 2.12(c)(6). This exception permits a staff member to satisfy his or her
state law reporting obligations with respect to suspected child abuse or neglect, but
does not remove the federal confidentiality protections from the patient's records
upon a follow up investigation.
68 §§ 2.61-2.67. Before such an order may be issued, the court must give
notice to the patient and the treatment program, must follow elaborate procedures to
contain disclosures attendant to the hearing process, must find "good cause" for the
information to be disclosed, and must limit the disclosure accordingly. Id. These
procedural and substantive requirements render this sort of an order much more diffi-
cult to obtain than other more familiar forms of compulsory process, such as warrants
and subpoenas.
69 The consent provisions of the federal regulations require that the patient's
waiver of confidentiality be in writing. This written form must identify the patient,
the treatment provider, and the recipient of information. In addition, it must contain a
statement of the purpose for the proposed disclosure, a description of the precise
information to be communicated, an identification of the date, event, or condition
upon which the consent will expire, and a statement that the consent is subject to
revocation at any time unless the program has already acted in reliance on it. See
§ 2.31.
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referral activities constitute the provision of diagnosis or treatment of
a kind contemplated by those laws and regulations. If the answer to
this question is yes, a host of potential obligations have to be met to
insure compliance with the law. The federal regulations contain ex-
plicit requirements with respect to maintaining the security of patient
records, and severely limit access to them.70 Unless information that
is "patient-identifying" (in the sense that it communicates facts relat-
ing to an individual's diagnosis, referral or treatment for a AOD dis-
order) is either segregated physically or electronically, these rules
would strictly limit the ability of medical staff and others within the
hospital to review the patient's chart or discuss the patient's status and
ongoing treatment. In addition, the restrictions on disclosure would
limit what medical personnel could say to a patient's family, friends,
or work colleagues.71 Moreover, these limitations generally are rigo-
rously enforced, and their violation carries potential civil and criminal
penalties.7 2
Clearly, under the original HEW regulations promulgated in the
1970s the answer to the question, whether emergency departments and
trauma centers undertaking AOD screening and intervention activities
would be subject to the federal AOD confidentiality regulations,
would have been in the affirmative, given that the term "program"
was broadly defined to include any entity "which, in whole or in part,
holds itself out as providing, and provides, alcohol or drug abuse di-
agnosis, treatment, or referral for treatment," and given that the term
"patient" was taken to include any person who had applied for or re-
ceived an interview, counseling, or other related service by a program,
even if the individual had never been admitted for treatment and even
if the program deemed that he or she was not in need of such servic-
es.73  In 1987, however, at the urging of hospitals and others
concerned about the administrative burdens resulting from this broad
application of the federal AOD confidentiality law, IHS revised the
confidentiality regulations to exempt general health-care facilities
such as hospitals and community mental health centers from the fed-
eral AOD confidentiality law's obligations.74 Even under the 1987
revisions, though, specialized AOD treatment units and individuals
within general health care facilities such as hospitals and CMHCs
70 See § 2.16.
71 §§ 2.12(a), 2.13(a)(b).
72 See § 2.4.
n Confidentiality of Alcohol and Drug Abuse Patient Records, 42 C.F.R.
§ 2.11 (1987).
74 Confidentiality of Alcohol and Drug Abuse Patient Records, 52 Fed. Reg.
21,796, 21,797 (June 9, 1987) (to be codified at 42 C.F.R. pt. 2).
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were still covered, if these units or individuals were identified as pro-
viding diagnosis, referral, or other treatment services for substance
use disorders.75
This was the state of the law in 1989, when the United States
Court of Appeals for the Ninth Circuit decided United States v. Eide.76
Eide involved the prosecution of a pharmacist for diverting controlled
substances. The defendant had been treated at a hospital emergency
room for substance abuse, and information relating to that emergency
room care had been made available as evidence in the criminal case
against him. On appeal, Eide argued that this information was subject
to the federal AOD confidentiality law and regulations and that no
exception in the law and regulations permitted its disclosure in this
instance. A majority of the Ninth Circuit panel agreed with Eide,
concluding that: (1) he was a "patient" within the meaning of the fed-
eral regulations; (2) the emergency room was a "program," and (3) the
lab results and statements Eide made to medical personnel in the
emergency room were protected "records."77
Under the 1987 amendments to the AOD confidentiality regula-
tions, an individual or other federally supported entity was still a cov-
ered "program" if it held itself out "in whole or in part" as providing
"alcohol or drug abuse diagnosis, treatment, or referral for treat-
ment." 78 In the context of a hospital or other "general care facility,"
however, the 1987 amendments additionally required that the provider
either be an "identified unit" which provides AOD services or "medi-
cal personnel or staff whose primary function" is the provision of such
services." The question in Eide was how to interpret these rules
given that the hospital emergency department in that case regularly
"perform[ed] functions unrelated to drug abuse" as well as functions
clearly falling within the definition of alcohol and other drug diagno-
sis, treatment, and referral for treatment.80  In concluding that the
emergency room's multiple functions did not exempt it from the fed-
eral confidentiality rules, the Ninth Circuit relied on the "in whole or
in part" language in the first part of the definition and concluded that
because the emergency room was a "vital first link" in the diagnosis,
referral, and treatment of substance abuse patients, some of whom
" 42 C.F.R. § 2.11 (1987) (defining the term "program").
76 875 F.2d 1429 (9th Cir. 1989).
77 Id. at 1435-36.
78 § 2.11.
79 .2
so 875 F.2d at 1436.
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ultimately ended up in a specialized treatment unit in the hospital, it
was an "identified unit" for purposes of the federal law.81
Eide did not settle the question of how expansively to read the
federal law and regulations in the context of hospital emergency de-
partments. In 1994, in order to limit the scope of the federal confiden-
tiality requirements in this setting and to clarify what it termed "the
ambiguity" in the regulations regarding the definition of a "program,"
the Substance Abuse and Mental Health Services Administration
("SAMHSA") proposed further amendments to the regulations. 82 In
its Notice of Proposed Rulemaking, SAMHSA pointed out that the
1987 amendments had been intended to exclude non-specialized units
within general hospitals, presumably including most emergency de-
partments, on the theory that including such entities did not serve
Congress's expressed purpose of:
enhanc[ing] treatment incentives for alcohol and drug abuse,
since many substance abuse patients are treated in a general
medical care facility not because they have made a decision to
seek substance abuse treatment, but because they have suf-
fered a trauma or have an acute condition with a primary di-
agnosis of something other than substance abuse.
The SAMHSA regulators proposed a restructured definition of the
term "program" in the hope, only partially realized, that this restruc-
turing would clarify the issue that had been raised in Eide.
The revised regulatory language, which is the currently applicable
provision, deleted the "in whole or in part" language and reworked the
previous definition by organizing it into a three-part disjunctive test.84
The first prong is limited explicitly to individuals and groups "other
81 Id.
82 Alcohol and Drug Abuse Patient Records, 59 Fed. Reg. 42,561, 42,562
(proposed Aug. 18, 1994) (to be codified at 42 C.F.R. pt. 2).
83 Alcohol and Drug Abuse Patient Records, 59 Fed. Reg. at 42,561, 42,562.
8 The relevant language in 42 C.F.R. § 2.11 (2008) is as follows:
Program means:
(a) An individual or entity (other than a general medical care facility) who
holds itself out as providing, and provides, alcohol or drug abuse diagnosis,
treatment or referral for treatment; or
(b) An identified unit within a general medical facility which holds itself
out as providing, and provides, alcohol or drug abuse diagnosis, treatment
or referral for treatment; or
(c) Medical personnel or other staff in a general medical care facility
whose primary function is the provision of alcohol or drug abuse diagnosis,
treatment or referral for treatment and who are identified as such providers
than a general medical care facility" who hold themselves out as pro-
viding AOD-related services." The second and third prongs then take
up the instance of AOD treatment providers operating within a general
hospital or other general health-care facility. Prong two includes as a
regulated program "an identified unit" within such an institution if it
"holds itself out as providing, and provides, alcohol or drug abuse
diagnosis, treatment or referral for treatment." 86 Notably, this second
prong still does not address explicitly the question of how to categor-
ize an identified unit that holds itself out as providing both AOD di-
agnosis and treatment as well as other non-AOD related services. The
third prong, by contrast, does directly deal with this problem of mul-
tiple functions. It provides that "medical personnel or other staff' in a
general hospital or other general care facility are regulated as a "pro-
gram" under the federal regulations if their "primary function" is the
provision of AOD services and they are "identified as such provid-
ers."87 Thus, even after the promulgation and adoption of these most
recent amendments to section 2.11 's definition of a "program," we are
still left with linguistic ambiguity regarding how to treat hospital
emergency departments and trauma centers whose "primary function"
is not to provide AOD services, but who hold themselves out as pro-
viding those services as part of a broader array of emergency health-
care functions.
85 id
86 id
87 id
88 The question whether emergency departments hold themselves out as
"providing alcohol or drug abuse diagnosis, treatment or referral for treatment" re-
quires some consideration of the Emergency Medical Treatment & Labor Act
(EMTALA), which was promulgated by Congress in 1986 to insure public access to
emergency services regardless of a patient's ability to pay. See 42 U.S.C. § 1395dd
(2006). Pursuant to the EMTALA, Medicare-participating hospitals that offer emer-
gency services have a statutory obligation to provide an appropriate medical screen-
ing examination (MSE) when a patient comes to the emergency department and a
request is made for examination or treatment for a medical condition, and a statutory
duty to provide treatment to stabilize the patient's emergency condition or to transfer
the patient for appropriate stabilizing treatment. The purpose of the required MSE is
to determine if the patient's presenting condition is an emergency medical condition,
as defined in the law. Importantly, the Centers for Medicare and Medicaid Services
(CMS) regard alcohol intoxication to be a "sufficiently severe medical symptom to
warrant the label 'emergency medical condition."' 59 Fed. Reg. 32,107-32,108 (June
22, 1994). Thus, at least for those patients who exhibit behavioral or other symptoms
of significant substance misuse, federal law would appear to require emergency de-
partment staff to undertake AOD screening activities as part of their general obliga-
tions to provide appropriate medical examinations. Implicitly, then, an emergency
department subject to EMTALA that holds itself out as providing emergency services
also holds itself out as providing substance abuse screening as part of the MSE made
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Notwithstanding this lacuna in the regulatory language, SAMHSA
sought to provide guidance to emergency departments in its 1994 No-
tice on confidentiality coverage. Specifically, the regulators indicated
that, while individuals with an AOD treatment specialization working
in an emergency room or trauma center would be covered by the fed-
eral regulations only if their primary function was AOD treatment, the
emergency room "as a whole" would be covered so long as it had
"promoted itself to the community as providing such services."9
The amended language of the regulations together with this prom-
ulgation history was further interpreted by the United States Court of
Appeals for the Tenth Circuit in Center for Legal Advocacy v.
Earnest.90 In Earnest, a Tenth Circuit panel reversed a District Court
decision that had followed Eide, on the grounds that the District
Court's opinion had been superseded by the subsequent amendments
to the federal regulations.91 Even with the new three-part definition of
"program," the Tenth Circuit panel still had some work to do to sup-
port its conclusion that the AOD regulations did not apply to the hos-
pital emergency room in this case. The issue arose following the
death of a patient who had been treated in the hospital's emergency
department and then transferred to its intensive care unit. The pa-
tient's death was being investigated by the plaintiff, which had been
statutorily mandated to "investigate incidents of abuse and neglect of
individuals with mental illness." 92 The hospital had resisted the plain-
tiff's efforts to obtain information about the deceased's emergency
department care, on the grounds that that information was protected
by the federal AOD confidentiality law and regulations.93
Directing its attention initially to the third prong of the new defi-
nition, the court concluded that nothing in the record supported a find-
available to patients exhibiting signs of intoxication. What is less clear is whether the
EMTALA requirement that patients receive a MSE provides a legal basis for arguing
that other emergency department patients should receive AOD screening services as
well. If that interpretation were adopted, of course, there would be an even stronger
claim of holding out.
89 Alcohol and Drug Abuse Patient Records, 59 Fed. Reg. 42,561, 42,562
(proposed Aug. 18, 1994) (to be codified at 42 C.F.R. pt. 2).
90 320 F.3d 1107, 1111-12 (10th Cir. 2003).
9' Id. at 1110-11, 1112.
92 Id. at 1109. The plaintiff in this case had been designated a protection and
advocacy organization under the federal protection and advocacy system. This sys-
tem, which is a creation of federal law, directs designated organizations to "investi-
gate incidents of abuse and neglect of individuals with [disabilities] and to take ap-
propriate action to protect and advocate the rights of such individuals." Id. (quoting
Iowa Prot. and Advocacy Servs. v. Gerard Treatment Programs, 152 F. Supp. 2d 1157
(N.D. Iowa 2001)).
9' Id. at 1109.
ing that individuals on the medical staff in the emergency room were
"primarily" providing AOD treatment services. 94 The court relied
upon deposition testimony of the associate director of emergency
medicine at the hospital that "the emergency room personnel . . .
[were] not identified specifically as licensed alcohol or drug abuse
treatment providers or counselors." In addition, the court noted that
the nurse who had provided the individual patient with care stated in
his deposition that he "was not a provider of alcohol abuse treatment
but rather a trauma nurse." 96
The Tenth Circuit panel also concluded that the emergency de-
partment of the hospital did not meet the requirements set out in the
second prong of the regulations' definition of a "program." The court
had to address the arguments of the hospital and of the District Court
that the emergency department was an "identified unit," because it
had a close working relationship with a specialized AOD treatment
unit within the hospital. 97 Faced with "significant evidence of integra-
tion" between the hospital's emergency room and its specialized
treatment unit for chronic substance use disorders, the Tenth Circuit
panel focused instead on questions of licensure and public relations.98
With respect to licensure, the court pointed out that hospital adminis-
trators had testified in deposition that neither the emergency
department itself nor any individual medical staff members within the
emergency room were licensed to provide ongoing care for chronic
AOD disorders.99 With respect to public relations, the court relied on
the fact that the emergency department had been marketed as provid-
ing a full range of emergency services but had not specifically held
itself out as providing AOD-related services.'0
It is becoming increasingly difficult to argue, however, that many
hospital emergency departments and trauma centers do not hold them-
selves out as providing alcohol and other drug diagnosis, counseling,
and referral services as a regular component of the health care they
94 Id. at 1111-12.
95 Id.
96 Id.
97Id. at 1112.
98 Id.
9 Id.
10 Id. ("While Dr. Cantrill testified that the emergency department holds
itself out as being a fully staffed emergency department and that drug and alcohol
abuse often includes medical emergencies, he admitted that the emergency depart-
ment made no claim that it provided any ongoing care for '[t]he more chronic compo-
nents of chronic alcohol or chronic drug abuse . . . .' [T]he Hospital had never made
significant efforts to market the emergency room as part of its drug and alcohol abuse
treatment program.").
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provide. At least in the case of Level I and II trauma centers, this type
of "holding out" is inherent in the requirements for COT certification,
and in the broad push that leaders within the field have made to ad-
vance the idea that AOD screening and intervention is and ought to be
an integral part of trauma care.lot
In addition, as more emergency departments and trauma centers
offer these services, the likelihood increases that patients with drug
and alcohol problems will be seen on the unit by individuals whose
"primary function is the provision of alcohol or drug abuse diagnosis,
treatment or referral for treatment and who are identified as such pro-
viders."' 0 2 While the patient in the Earnest case had not been treated
by a licensed alcohol or drug abuse treatment provider or counselor, in
other emergency department or trauma center settings, even if an ini-
tial screening can be accomplished by personnel without specialized
AOD training, the more intensive assessment of patients who screen
positive may require the involvement of an AOD specialist.'o3 Simi-
larly, the emergency department in Earnest had a "close working rela-
tionship" with a specialized AOD unit in the same hospital and could
have relied on staff of that unit to provide this sort of support." In
other settings, the trauma center or emergency department may have
an AOD specialist on staff or may arrange for a number of staff mem-
bers to be trained to conduct AOD screenings and interventions.105 To
some extent, these staffing decisions involve important policy choices
by hospital administrators and others about how best to balance the
goals of mainstreaming or integrating AOD diagnosis and treatment
on the one hand, and protecting the confidentiality of individual pa-
tients' drug and alcohol abuse information on the other. 06
Taking into consideration all of the foregoing, we can now begin
to organize an analysis around the elements of the federal AOD confi-
dentiality regulations. As we have seen, in order for the regulations'
limitation on the disclosure of information to apply, either the entire
unit or some identified individual or individuals within the unit would
have to be determined to be a "program," and the information would
have to relate to a "patient," defined by the regulations as someone
101 See supra text accompanying notes 13-21.
102 42 C.F.R. § 2.11 (2008) (see part (c) of the definition of "program").
103 See CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 4.
"4 Earnest, 320 F.3d at 1110, 1112.
'os See CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 1.
' See CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 6.
who has received AOD screening, assessment, intervention and/or
referral services.' 07 Putting aside for the moment the specific facts of
any given case, it may be possible to use standard tools of statutory
(or in this case regulatory) interpretation to help determine whether,
and under what circumstances, the federal confidentiality regulations
apply to the provision of AOD services by emergency departments
and trauma centers. On one side, proponents of applying AOD confi-
dentiality regulations in this setting could make a relatively
straightforward argument based upon the language and structure of
the federal regulations. This argument would center on the observa-
tion that only the third of the three prongs making up the definition of
"program" in section 2.11 contains an explicit "primary function"
requirement. Given that the three prongs are linked with the disjunc-
tive term "or," which means that each represents an alternative basis
for finding that an entity is covered, it is reasonable to conclude that
an emergency department or trauma center need not have as its prima-
ry function the provision of AOD services, so long as it otherwise
meets the requirements of the second prong of the definition contained
in section 2.11 (i.e., that it "holds itself out" as providing and does
provide AOD services, along with a wide range of other medical ser-
vices).10 8 In response, opponents to treating trauma centers and emer-
gency departments as covered "programs" would likely build an ar-
gument on SAMSHA's observation that "many substance abuse pa-
tients are treated in a general medical care facility not because they
have made a decision to seek substance abuse treatment, but because
they have suffered a trauma or have an acute condition with a primary
diagnosis of something other than substance abuse." 09 Thus, from
this perspective, the protections of the federal AOD confidentiality
regulations are unnecessary because concerns about the stigma asso-
ciated with substance abuse treatment are unlikely to dissuade patients
from seeking emergency or trauma care.
This purposive argument, while compelling, is not necessarily
conclusive, given the dual purposes served by the AOD confidentiali-
107 See 42 C.F.R. §§ 2.11-2.13; see also State v. Johnson, 163 Ohio App. 3d
132, 2005-Ohio-4243, 836 N.E.2d 1243, 1 37-41 (narrowly interpreting the term
"records" as it relates to "identity, diagnosis, prognosis, or treatment of any patient"
in the federal confidentiality regulations); Mitchell v. Mt. Hood Meadows Oreg., 99
P.3d 748, 754 (Or. Ct. App. 2004) (concluding substance use information did not
constitute a "diagnosis" and therefore was not the basis of a prohibited disclosure of
treatment records).
o 42 C.F.R. § 2.11.
09 Alcohol and Drug Abuse Patient Records, 59 Fed. Reg. 42,561, 42,562
(proposed Aug. 18, 1994) (to be codified at 42 C.F.R. pt. 2).
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ty laws and regulations. In addition to creating a generalized percep-
tion among potential patients that it is safe to seek substance abuse
treatment, the federal scheme also aims to protect individual patients
from the concrete harms that disclosure of their substance use disord-
ers could cause."o Thus, even if a given patient who has suffered
injuries in an automobile accident or who has suffered an acute medi-
cal emergency would be unlikely to avoid emergency care because of
the lack of AOD confidentiality protections in the emergency room,
harms could still flow to that individual if a positive alcohol or drug
screen or assessment were disclosed to family, friends, insurers or
employers.' 1
Under section 2.11, a "patient" is "any individual who has applied
for or been given diagnosis or treatment for alcohol or drug abuse" by
a covered program.112 Section 2.12(e)(1) states that the regulations
"cover any information (including information on referral and intake)
about alcohol and drug abuse patients obtained by a program," and
section 2.12(e)(4) provides that the regulations protect "any record of
a diagnosis identifying a patient as an alcohol or drug abuser which is
prepared in connection with the treatment or referral for treatment of
alcohol or drug abuse."' Here again, as with the regulations' defini-
tion of "program," considerable uncertainty exists about how to han-
dle screening and assessment information indicating that a patient has
a substance use disorder, particularly if that information has been ga-
thered by emergency or trauma center staff both for purposes of the
medical management of the patient's acute injuries or illness and also
as part of a universal screening and intervention policy.
Some commentators who have considered whether the AOD con-
fidentiality regulations should apply to emergency departments and
trauma centers have suggested that the answer should turn on the rea-
son why information about a patient's alcohol or other drug use has
been gathered. Thus, a consensus panel of experts convened by the
Center for Substance Abuse Treatment"14 has advised that if alcohol
screening is undertaken:
110 See supra text accompanying note 7.
S" ee CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 6.
112 42C.F.R. § 2.11.
§ 2.12(e)(1), (4).
114 The Center for Substance Abuse Treatment (CSAT) of the Substance
Abuse and Mental Health Services Administration (SAMHSA), within the U.S.
Department of Health and Human Services (HHS), promotes the quality and availa-
bility of community-based substance abuse treatment services for individuals and
families who need them. See Ctr. for Substance Abuse Treatment, U.S. Dep't of
Health & Human Servs., http://csat.samhsa.gov/ (last visited May 3, 2010).
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to effect the management of the presenting condition, it is
protected by general rules about patient confidentiality and
need not be treated differently from any other medical infor-
mation. To gain a complete and accurate clinical picture, a
physician needs access to all of a patient's records concerning
history and present condition. Such information should in-
clude whether there is an underlying pattern of substance
abuse, since this information may have a bearing on the pa-
tient's condition. AOD screening may be done in order to
identify antecedent problems or conditions that may have an
impact on the medical management of the patient's presenting
condition. This information, then, gathered for the purpose of
managing the present condition, would not be subject to the
Federal regulations."'
While this approach clarifies the situation when AOD screening is
conducted solely for purposes of medical management, it does not
provide guidance about whether an emergency department or trauma
center patient becomes an AOD "patient" for purposes of the federal
regulations when the information has been obtained both to treat the
presenting condition and as part of a broad program of AOD screen-
ing and intervention. Indeed AOD information, including laboratory
screens and other diagnostic tests and assessments, may be generated
both for the purpose of medically managing the presenting condition
and for the purpose of identifying patients with substance use disord-
ers in order to provide them interventions at a moment when this sort
of counseling may be most effective. Here, then, as with the regulato-
ry definition of "program," the problem of multiple functions appears
not to be clearly resolved by either the language or the structure of the
federal regulations, taken on their own terms.
This failure of the federal AOD confidentiality regulations to re-
solve clearly the problem of multiple functions likely results from the
fact that the treatment of most AOD patients in the United States has
historically been provided by separate, specialized clinicians.' Thus,
regulatory language restricting the application of the federal regula-
tions to an "identified unit within a general medical facility" or to
personnel whose "primary function is the provision of alcohol or drug
abuse" treatmentil 7 reflects the reasonable assumption that medical
personnel whose primary responsibilities involve the provision of
"' See CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 6.
116 See supra note 6 and accompanying text.
117 42 C.F.R. § 2.11.
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non-AOD related health-care services do not regularly provide sub-
stance abuse diagnosis or treatment as well.
Moreover, the gap in the law also stems from the fact that the fed-
eral regulations are built around a conception of alcohol and other
drug problems that diverges from the operating premise of the new
movement to offer screening, assessment, intervention, and referral
services broadly in emergency departments and trauma centers. Thus,
the AOD regulations reflect a "dispositional disease model,""' that
has dominated thinking about substance use disorders since at least
the middle of the twentieth century. In the case of alcohol use, this
model dichotomizes the population into a small set of persons who are
"alcoholics" and a much larger group for whom the ingestion of alco-
hol is not dangerous. The key difference between these two groups is
that alcoholics are thought to have an "abnormal, constitutional dispo-
sition influenced by enduring biological factors" that causes them to
lose control over their drinking behavior.119 According to this "dis-
ease model" of alcoholism, the disease, "although incurable, can be
suppressed through abstinence."l 20
Although the dispositional disease model has stimulated the de-
velopment of effective treatment for persons with alcohol dependen-
cy, it has not addressed the significant harms that non-dependent
problem drinkers can suffer.121  An important premise behind the
screening and intervention approach, by contrast, is that not all sub-
stance abusers fall within the "dispositional disease model," but in-
stead can be located across a continuum marked at one end by persons
who are alcohol dependent and at the other end by persons who are
either risky drinkers or who engage in problem drinking.1 22 It is, in
part, in order to advance the health interests of this much larger group
of problem drinkers that screening, assessment, and intervention strat-
egies have been developed for emergency department and trauma
center settings.
As recognized by the Institute of Medicine in its 1990 report
Broadening the Base of Treatment for Alcohol Problems, acceptance
"8 Hungerford, supra note 6, at S 10-11.
"9 Id.
120 Id. at S1O.
121 See id. at S I1; see also Saitz, supra note 9.
122 For a discussion of this new paradigm for thinking about the range of
problems associated with alcohol consumption, see Saitz, supra note 9. While the
chemical properties of drugs other than alcohol vary, as do the precise physical effects
of their ingestion, the idea that the problems of misuse fall out along a continuum
from severe chemical dependency at one end to the risks of occasional use at the other
remains a useful construct for thinking about the development of regulatory and pub-
lic health policy.
of the dispositional disease model has led to the development in the
United States of a specialist AOD treatment system focused on alco-
holics and other addicts that is not well suited to meeting the needs of
patients who may suffer from mild-to-moderate problems with sub-
stances of abuse.12 3 Because this latter group is much larger than the
population targeted by the specialist AOD treatment system, it proba-
bly accounts for a correspondingly higher percentage of the AOD-
related injuries seen in emergency departments and trauma centers.
Consequently, the idea of providing a general regime of screening,
assessment, and intervention services in these settings has taken hold
as a means of preventing a broader range of diseases and injuries re-
lated to substance abuse.124
Importantly, the regime of screening and intervention activities
contemplated by this new paradigm is systematic and not an incidental
feature of the care offered by the emergency departments and trauma
centers that have adopted this approach. It is in this respect specifical-
ly that the assumptions behind the federal AOD confidentiality regula-
tions fail to square with the new and developing public health oriented
practice of emergency and trauma center staff. In its 1994 Notice of
Proposed Rulemaking relating to the AOD confidentiality regulations,
HHS explained that:
these regulations do not apply to alcohol or drug abuse pre-
vention programs, whether based in general care facilities or
otherwise, which do not hold themselves out to the communi-
ty as providing alcohol or drug abuse diagnosis, treatment or
referral for treatment, even though such programs may occa-
sionally refer individuals to treatment for substance abuse as
an incidental function of the prevention program.125
In addition, HHS stated that "although the regulations would not ordi-
narily apply to a staff physician of an emergency room or an intensive
care unit who refers an overdose patient to a drug abuse treatment
practitioner, they would apply to a drug abuse treatment practitioner
whose primary function is to provide such services."l 2 6 What both of
these statements fail to recognize is that, regardless of whether there is
an explicit "holding out," staff physicians and others in emergency
123 See Comm. on Treatment of Alcohol Problems, INST. OF MED., supra note
I1, at 84-86.
124 See Gentilello et al., supra note 3, at 1253-54.
125 Alcohol and Drug Abuse Patient Records, 59 Fed. Reg. 42,561, 42,562
(proposed Aug. 18, 1994) (to be codified at 42 C.F.R. pt. 2).
126 id
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and trauma settings increasingly are screening for and intervening
with patients who have alcohol and other drug problems, not on an
occasional or exceptional basis, but systematically and as a regular
feature of their clinical practices.127 Some of these patients will be
identified as alcohol or drug dependent and in need of specialist AOD
treatment, others will be assessed as problem or risky users who may
benefit from a brief intervention or other counseling services linked
closely to the immediate circumstances of the particular patient's hos-
pital admission.12 8 In either case, the treatment professionals will
have obtained information relating to the patient's abuse of alcohol or
other drugs, information that could be harmful to the individual if
disclosed. In light of the systematic nature of this diagnostic, counsel-
ing, and referral activity, and in light of the potential harms that dis-
closure could produce, the better approach may be to regard these
screening and intervention programs as covered by the AOD confi-
dentiality regulations.
III. OPERATIONALIZING THE FEDERAL
CONFIDENTIALITY LAW AND REGULATIONS IN
THE CONTEXT OF EMERGENCY DEPARTMENTS
AND TRAUMA CENTERS
Once the federal confidentiality regulations are deemed to apply
to emergency department and trauma center screening and interven-
tion activities, a second-order question is whether the regulations
should cover the entire unit as the "program" or whether individual
AOD specialists (if they are employed on the unit) should be desig-
nated as the "program."1 29 If the latter approach were adopted, the
restrictive disclosure requirements of the federal regulations would
not apply to all the staff members on the unit in their communications
of information about patients who receive screening and intervention
services, although the AOD specialist or specialists would be prohi-
bited from disclosing patient-identifying 30 information to their non-
specialist colleagues. In contrast, if the entire unit were regarded as
127 See supra notes 29-42 and accompanying text.
128 See Field et al., supra note 41, at S24-25.
129 See generally Gentilello et al., supra note 3, at 1251-52 (discussing the
legal parameters of disclosing a patient's alcohol or drug use disorder to other health
care professionals within the same treatment facility).
130 For purposes of the federal AOD confidentiality laws and regulations, a
disclosure is "patient identifying" if it identifies an individual as a recipient of alcohol
or other drug diagnosis, treatment, or referral services. See supra text accompanying
note 63.
the "program," then the more demanding federal AOD regulations
necessarily would play a role in shaping the information management
practices of all staff members of the emergency department or trauma
center. Even in this circumstance, however, only information identi-
fying the patient as having received AOD diagnosis, treatment, or
referral for treatment would be subject to the regulations' restrictions
on disclosure. Thus, information limited to the patient's receipt of
other health-care services would not be subject to the more robust
requirements of the federal AOD regulations.1 31
In settings where the entire unit is treated as the "program" for
these purposes, AOD information could be segregated physically or
electronically in separate files, in order to prompt staff not to share
this information with colleagues within the program in circumstances
in which its communication would not be necessary in order to sup-
port the treatment of the patient's AOD problem, and to prevent its
communication to others outside the program as well. 132  In units
where some (but not all) of the individual staff members are designat-
ed as the "program," the need for segregated record-keeping systems
would be even more urgent, because the specialist staff members
would not be able to rely on the internal program communication ex-
ception contained in the regulations in order to share information with
others providing care to the patient on the unit.' 33
The internal program communication exception is one of at least
three ways that the federal confidentiality regulations would permit
the sharing of patient-identifying information by an emergency de-
partment or trauma center that is designated a "program." As noted
above, a communication of information that is patient identifying is
not a prohibited disclosure under the regulations if it takes place
1' Confidentiality of Alcohol and Drug Abuse Patient Records, 42 C.F.R.
§§ 2.11, 2.12(e)(4) (2008).
132 CTR. FOR SUBSTANCE ABUSE TREATMENT, U.S. DEP'T OF HEALTH &
HUMAN SERVS., supra note 25, at ch. 7; Gentilello et al., supra note 3, at 1253-54.
Given the stigma associated with drug use disorders, even the disclosure of informa-
tion about a patient's addiction and treatment to other health care providers can
present risks to the patient. Thus, one published article reports that:
[the] director of training and recovery services for the National Association
of Medication Assisted Recovery, has been told by the physician in charge
of his treatment that he should not tell other doctors that he's on methadone,
but rather should have them contact the opioid treatment program (Beth
Israel Medical Center). 'What happens is as soon as they hear you're a me-
thadone patient, they assume you're drug seeking and you don't get good
treatment,' he said.
Battle Lines Drawn over Patient Confidentiality Issues, ALCOHOLISM DRUG ABUSE
WEEKLY, Mar. 8, 2010, at 1, 1, 3.
"3 42 C.F.R. § 2.12(c)(3).
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"within the program" (i.e., between program staff) and is undertaken
in connection with the recipient's duties in the provision of alcohol or
other drug treatment services.134 Employing this exception, a trauma
surgeon or other staff member could share information about a pa-
tient's substance abuse with a colleague in order to assist in the reci-
pient's performance of an AOD assessment, in order to facilitate an
AOD intervention or referral, or to further any other activity fairly
regarded as the provision of AOD diagnosis or treatment. On the oth-
er hand, a communication of patient-identifying information from one
staff member to another for purposes of providing health-care services
not directly related to the diagnosis or treatment of a patient's alcohol
or other drug use disorder would not qualify for the internal program
communication exception and would be prohibited by the federal
AOD regulations, unless another exception to the general prohibition
on disclosure applied.
For disclosures outside the "program," the federal AOD regula-
tions permit the use of what are termed "qualified service organization
agreements" (QSOA).' 35 Under the regulations, an outside entity that
provides one or more of a wide range of services (e.g., laboratory,
billing, legal, and other medical services) to an AOD treatment pro-
gram may receive patient-identifying information without obtaining
individual patient consent, if the outside service provider enters into a
written agreement under which it agrees to abide by all of the re-
quirements of the confidentiality regulations as if it were a covered
program.136 In effect, the QSOA provision brings the outside service
provider within the treatment program for these purposes, thus making
the sharing of patient-identifying information an internal program
communication and not a prohibited disclosure.137 While longstand-
ing HHS interpretations have maintained that two AOD treatment
programs may not enter into a QSOA arrangement with one
another,'38 it is clear that an AOD treatment program may communi-
cate patient-identifying information pursuant to a QSOA with an out-
side health-care provider who is furnishing primary medical services
134 id.
135 § 2.12(c)(4).
136 id.
137 id.
1' See, e.g., U.S. DEP'T OF HEALTH AND HUMAN SERVICES, PUB. HEALTH
SERVICE, OFFICE OF THE GEN. COUNSEL, LEGAL OPINIONS ON THE
CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS 1975-
1978, at 79 (1980). For example, a detoxification facility and a long-term follow-up
care facility may not enter into a QSOA with one another to facilitate patient referrals.
See id.
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to the AOD program's patients in a fashion that supports the underly-
ing alcohol and other drug treatment.13 9 Depending on the particular
circumstances, QSOAs could conceivably be executed in order to
permit the sharing of otherwise confidential information between staff
members of an emergency department or trauma center covered
by the federal AOD regulations and other non-AOD health-care
professionals.
Finally, the federal regulations permit the disclosure of informa-
tion identifying a patient as the recipient of AOD diagnosis, treatment
or referral services, if the patient provides proper written consent.140
The regulations are unusually detailed in setting out the elements of
an effective patient consent form. The form must contain the name of
the patient, the treatment program, and the recipient of the informa-
tion. In addition, the consent form must contain a statement of the
purpose for the proposed disclosure, a description of the precise in-
formation to be communicated, an identification of the "date, event, or
condition upon which the consent will expire," and a statement that
the consent is subject to revocation by the patient at any time unless
the program has already acted in reliance on it.141
While patients who are conscious and competent at the time of
their admission to an emergency department or trauma center could be
asked to execute a written consent form at that time, the logic of the
consent provisions suggests that programs should not seek broad,
open-ended permission to share AOD information. 142 Moreover, giv-
en the circumstances and nature of the presenting conditions typical of
patients in these units, many patients will not be conscious or compe-
tent upon admission. The federal regulations do not permit family
members, friends, or others responsible for a patient to give consent
on his or her behalf, unless the third party is the patient's legal guar-
dian, and no explicit provision is made for substitute consent (for
most purposes) in the case of a medical emergency.14 3 Thus, although
139 See LEGAL ACTION CTR., CONFIDENTIALITY: A GUIDE TO THE FEDERAL
DRUG & ALCOHOL CONFIDENTIALITY LAW AND HIPAA 35 (2006).
140 See 42 C.F.R. § 2.31.
141 Id.; see also Boldt, A Study in Regulatory Method, supra note 49, at 2333
(describing the required criteria for effective written consent).
142 42 C.F.R. § 2.31. This is because the structure of the consent provisions
contemplates that individual consent forms will be executed by patients in light of the
stated purpose for the disclosure that is being permitted.
143 In the case of a patient who has been adjudicated incompetent by a court,
consent to disclose patient-identifying information may be given by the patient's
lawfully appointed guardian or legal representative. § 2.15(a)(1). If the director of
the program determines that a patient's medical condition prevents "knowing or ef-
fective action on his or her own behalf," but there has been no adjudication of incom-
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some patients may be in a position to give consent at a later point, the
consent provisions of the regulations are unlikely to be a complete
solution to the problem of authorizing the disclosure of confidential
information in the course of emergency department or trauma center
staff undertaking assessment, intervention and referral services.
In the final analysis, notwithstanding these significant limitations
in the AOD regulations, because HIPAA has altered the default envi-
ronment for hospitals more generally with respect to patient privacy
and information management, the administrative inconvenience of
requiring segregated record-keeping may not be as great as one might
at first think. Under HIPAA's Privacy Rule, health care professionals
and administrators are required to employ different standards depend-
ing upon whether a proposed communication of patient information is
intended for third-party payers, family members or others with an
obligation of care, other health care providers, and the like.'" A clear
interrelationship exists between the federal standards for AOD infor-
mation, the federal HIPAA standards, and the various state law patient
privacy standards that hospitals must meet. 145 The question is whether
petency, the program director may authorize a disclosure without patient consent, but
only for the purpose of obtaining reimbursement from a third-party payer.
§ 2.15(a)(2).
'4 §§ 164.510, 164.522, 164.524.
145 With respect to the issue of a potential conflict between the two federal
health privacy schemes under consideration - the HIPAA Privacy Rule and the feder-
al AOD confidentiality regulations - it is important to move beyond the question of
which is more stringent, to a determination instead, as HHS stated in the preamble to
the proposed Privacy Rule, of whether a conflict exists. The separate question of
which of several provisions is more stringent is meant to apply primarily to conflicts
between federal and state law. In determining whether two federal provisions are in
conflict, the HHS preamble directs attention to whether the relevant provisions are
permissive or mandatory. Thus, if one provision is permissive (e.g., HIPAA's ap-
proach to the disclosure of patient information without individual written permission
for payment purposes) while the other is mandatory (e.g., the AOD regulations' re-
quirement of written patient consent), then there is no conflict because the mandatory
requirements of the latter scheme would necessarily apply. Thus, HHS explained
that:
the first principle that applies where both the HIPAA standards and imple-
mentation specifications and the requirements of another federal program
apply is that we must seek to reconcile and accommodate any apparently
conflicting federal requirements. Two conclusions flow from this principle.
First, where one federal statute or regulation permits an activity that another
federal statute or regulation requires, and both statutes apply to the entity in
question, there is no conflict, because it is possible to comply with both sets
of federal requirements. Second, where one federal statute or regulation
permits, but does not require, an activity that another federal statute or
regulation prohibits, there is again no conflict, because it is possible to
comply with both sets offederal requirements.
policymakers should drop to the lowest common denominator (often
HIPAA), in order to minimize or avoid the administrability costs as-
sociated with maintaining separate standards, or whether the benefits
to patients derived from a more complex legal regime are worth the
effort. This is a difficult empirical question that researchers have not
squarely addressed.146
As the foregoing discussion suggests, the federal AOD law and
regulations can plausibly be read either as applying to emergency de-
partment and trauma center screening and intervention programs, or
not. Fundamentally, this indeterminacy is due to the failure of the
drafters of these provisions to foresee that AOD problems do not oc-
cur bi-modally, as the dispositional disease model presumes, but in-
stead fall out along a broader continuum. Framed in this way, the
precise question is whether diagnosis and counseling functions di-
rected at individuals in the middle of the continuum and at the less
severe end should be regarded as covered AOD "treatment."
Perhaps it is worth considering the adoption of a limited use ex-
ception in the context of patient confidentiality rules governing AOD
treatment within emergency departments and trauma centers.14 7 Such
64 Fed. Reg. 59,918, 59,999-60,000 (Nov. 3, 1999) (Proposed rule) (emphasis added).
Importantly, HHS addressed this question explicitly in the preamble with regard to 42
CFR Part 2. See 64 Fed. Reg. 59,918, 60,001 (Nov. 3, 1999).
146 It is worth noting, however, that HHS's position that the AOD regulations
should not apply to general medical facilities, other than specialized units, was driven
by considerations of administrative expense and inconvenience. Thus, in Congres-
sional testimony about the proposed regulations, the regulators explained that
"[a]pplicability to specialized programs will lessen the adverse economic impact of
the current regulations on a substantial number of facilities which provide alcohol and
drug abuse care only as an incident to the provision of general medical care." Confi-
dentiality of Alcohol and Drug Abuse Patient Records, 52 Fed. Reg. 21796, 21797
(June 9, 1987) (to be codified at 42 C.F.R. pt. 2).
147 On February 5, 2010, a proposal of this sort was released by a group call-
ing itself the "Patient Protection Coalition." This group, which is led by Professor
Richard J. Bonnie of the University of Virginia School of Law and Dr. Eric Goplerud
of George Washington University, proposed amending the federal AOD confidentiali-
ty law and regulations to:
permit[] very limited disclosures of information about substance use disord-
er treatment to health care providers and health plans for purposes of treat-
ment, coordination of care, recovery support, quality improvement, disease
management and payment. Disclosures allowed by the proposal are much
more restricted than those allowed by the HIPAA Privacy Rule. Further,
the only items that can be disclosed without authorization for these two li-
mited exceptions are demographic information, diagnosis, medications, la-
boratory results, and identification of past or current treatment providers.
RICHARD BONNIE ET AL., PATIENT PROTECTION COALITION, A PROPOSAL TO PROMOTE
COORDINATION OF CARE AND TO STRENGTHEN PATIENT PROTECTIONS UNDER THE
FEDERAL ALCOHOL AND DRUG ABUSE CONFIDENTIALITY LAW (2010),
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an exception has been created within the federal AOD laws and regu-
lations to permit treatment programs to comply with state child abuse
reporting requirements (at least with respect to an initial report, if not
as to follow-up investigations by departments of social services).148
Other such exceptions have been considered and rejected in the past,
and new exceptions should be carefully scrutinized and limited. This
is particularly the case because once opened up, there would be consi-
derable political pressurel 49 to create rules permitting disclosures to
criminal justice system officials.5 o In the case of communicable dis-
ease reporting (including HIV), the AOD treatment community has
managed to make state law disclosure regimes work within the exist-
ing provisions of the federal confidentiality regulations.'"' Thus, tak-
en as a whole, the history in this area suggests that considerable
circumspection is called for before significant amendments are
undertaken.152
http://www.law.virginia.edu/pdf/faculty/bonniepatientprotection.pdf (on file with
author); see also Battle Lines Drawn over Patient Confidentiality Issues, supra note
132, at 1.
148 Section 2.12(c)(6) of the federal AOD confidentiality regulations provides
that:
The restrictions on disclosure and use in these regulations do not apply to
the reporting under State law of incidents of suspected child abuse and neg-
lect to the appropriate State or local authorities. However, the restrictions
continue to apply to the original alcohol or drug abuse patient records main-
tained by the program including their disclosure and use for civil or crimi-
nal proceedings which may arise out of the report of suspected child abuse
and neglect.
42 C.F.R. §§ 2.12(c)(6); see also supra text accompanying note 67.
149 Concern about this risk has been raised by AOD treatment advocates,
including groups like Faces and Voices of Recovery, and the Legal Action Center.
See also Battle Lines Drawn over Patient Confidentiality Issues, supra note 132, at 1.
The latter group has explained that "[a]mending the underlying statute would create
great - and we strongly believe unacceptable - risk that bedrock protections
could be eviscerated during the legislative process." See LEGAL ACTION CTR.,
CONFIDENTIALITY OF ALCOHOL AND DRUG RECORDS IN THE 21sT CENTURY (2010),
http://www.privatepractice.org/ConfidentialityofAlcohol.pdf.
150 It is important to remember that treatment for ongoing drug abuse is dif-
ferent than treatment for other diseases, including other mental illnesses, because of
the legal jeopardy that attaches to the possession of a controlled substance.
151 AOD treatment providers can comply with state HIV reporting and
tracking requirements without violating the federal confidentiality regulations by
obtaining patient consent or using qualified service organization agreements. In
addition, it often is possible to communicate relevant information without disclosing
the patient's AOD status, thus preventing the communication from being a prohibited
"disclosure" under the federal regulations.
152 For a good example of this sort of circumspection, see J. Zoe Beckerman
et al., Cal. Healthcare Found., Mar. 2008, http://www.chcf.org/~/media/Files/PDF/A/
ADelicateBalanceBehavioralHealthAndPrivacyB.pdf. A variation of this paper, by
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CONCLUSION
As the foregoing discussion suggests, the existing provisions in
the federal law and regulations governing the confidentiality of alco-
hol and other drug use treatment were not written with the new
screening and intervention activities of emergency departments and
trauma centers in mind. In other contexts,s 3 however, these provi-
sions adequately accommodate the interests of patients and of the
AOD treatment system on the one hand and satisfy concerns relating
to administrative convenience and expense on the other. The rules
dealing with patient consent, internal program communications, and
QSOAs represent sensible judgments in this area of public policy. Of
course, they presume an AOD treatment system that is not well inte-
grated into the broader health-care delivery system, and that is to be
regretted. Notwithstanding the inhibiting effect that the federal AOD
confidentiality rules may have on future efforts toward mainstreaming
addictions services, however, the fact remains that the dangers of un-
toward disclosure of this patient information are still very real. Ac-
cordingly, it would be premature to progress far down the road of
statutory or regulatory amendments in anticipation of an integrated
system that does not yet exist, so long as that legal jeopardy persists.
the same authors, was published by BNA in its Health Care Policy Report. J. ZOE
BECKERMAN ET AL., BNA, HEALTH INFORMATION PRIVACY, PATIENT SAFETY, AND
HEALTH CARE QUALITY: ISSUES AND CHALLENGES IN THE CONTEXT OF TREATMENT
FOR MENTAL HEALTH AND SUBSTANCE USE (2008), http://ihcrp.georgetown.edu/pdfs/
pritts0208.pdf.
153 These other contexts include, at a minimum, situations in which the shar-
ing of information is required in order to support research, audit and evaluation func-
tions, to facilitate program funding and administration, to coordinate care with other
mental health and general health care providers, and to encourage clients' job training
and employment activities.
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